Correlation Between Caribou Biosciences and Molecular Partners

Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Caribou Biosciences and Molecular Partners AG, you can compare the effects of market volatilities on Caribou Biosciences and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Molecular Partners.

Diversification Opportunities for Caribou Biosciences and Molecular Partners

0.37

Correlation Coefficient

Caribou Biosciences  Molecular Partners

Weak diversification

The 3 months correlation between Caribou and Molecular is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Molecular Partners go up and down completely randomly.

Pair Corralation between Caribou Biosciences and Molecular Partners

Given the investment horizon of 90 days Caribou Biosciences is expected to generate 11.4 times less return on investment than Molecular Partners. But when comparing it to its historical volatility, Caribou Biosciences is 1.43 times less risky than Molecular Partners. It trades about 0.01 of its potential returns per unit of risk. Molecular Partners AG is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  462.00  in Molecular Partners AG on September 25, 2024 and sell it today you would earn a total of  82.00  from holding Molecular Partners AG or generate 17.75% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Caribou Biosciences  vs.  Molecular Partners AG

Caribou Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Caribou Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, Caribou Biosciences is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Molecular Partners

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Molecular Partners AG are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady essential indicators, Molecular Partners displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Caribou Biosciences and Molecular Partners

The main advantage of trading using opposite Caribou Biosciences and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.

The idea behind Caribou Biosciences and Molecular Partners AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.